Top Diagnostics Stocks in India by Market Capitalization

    Listen to our Podcast: Grow your wealth and keep it secure.

    0:00 / 0:00

    This blog provides an overview of the leading diagnostics stocks in India based on market capitalization. The healthcare sector depends on diagnostics companies to perform disease diagnosis and monitoring which supports effective healthcare delivery.

    Top 5 Diagnostics Stocks in India You Should Know

    The following table provides a detailed snapshot of key diagnostics stocks in India, ranked by their market capitalisation. These companies are involved in diagnostic services across segments such as pathology, radiology, and life sciences.

    Company Name

    Last Price (₹)

    % Change

    52-Week High (₹)

    52-Week Low (₹)

    Market Cap (₹ Cr)

    Segment

    Dr Lal PathLabs

    2,478.10

    -0.85

    3,645.00

    2,168.80

    20,714.87

    Hospital & Healthcare Services

    Vijaya Diagnostic

    1,001.00

    0.02

    1,276.75

    629.15

    10,273.89

    Hospital & Healthcare Services

    Metropolis

    1,562.60

    -1.51

    2,306.85

    1,530.10

    8,013.19

    Hospital & Healthcare Services

    Thyrocare Tech

    683.40

    -2.48

    1,053.05

    570.75

    3,621.57

    Hospital & Healthcare Services

    Suraksha Diagnostic

    257.80

    -1.47

    449.00

    233.15

    1,342.64

    Labs & Life Sciences Services

    Source: MoneyControl as of 31 Mar’25

    Overview of Diagnostics Stocks

    This summary table highlights the top diagnostics players based on their overall market capitalisation, offering a quick comparison.

    Company Name

    Market Cap (₹ Cr)

    Dr Lal PathLabs

    20,714.87

    Vijaya Diagnostic

    10,273.89

    Metropolis

    8,013.19

    Thyrocare Tech

    3,621.57

    Suraksha Diagnostic

    1,342.64

    Source: MoneyControl

    Dr Lal PathLabs

    Dr Lal PathLabs Ltd operates as one of the leading diagnostic service providers in India. The company operates from New Delhi while providing a broad selection of tests through their laboratory facilities and sample collection points. The organization maintains its growth strategy through both international market penetration and operational performance improvements.

    Dr Lal PathLabs – Financial Overview

    Metric

    Value

    Market Capitalisation (₹ Cr)

    20,720

    Last Price (₹)

    2,478.80

    52-Week High (₹)

    3,653.95

    52-Week Low (₹)

    2,165.80

    TTM PE Ratio

    49.72

    TTM EPS (₹)

    49.86 (+16.36% YoY)

    P/B Ratio

    10.36

    Book Value Per Share (₹)

    239.45

    Dividend Yield (%)

    0.97

    Return on Equity (%)

    19.34

    Debt to Equity Ratio

    0.05

    Latest Quarterly Revenue

    ₹596.70 Cr (Q3 FY25)

    Source: MoneyControl

    Highlights

    ● Q3 FY25 net sales up 10.73% YoY.

    ● Minimal debt and stable ROE.

    ● Promoter holding slightly reduced to 53.91% in Dec 2024​.

    Metropolis Healthcare

    Metropolis Healthcare Ltd. operates as a major diagnostic company that delivers specialized testing services between pathology and molecular diagnostics. Through acquisitions Metropolis Healthcare Ltd. continues to expand while maintaining a wide network of facilities throughout major urban areas.

    Metropolis Healthcare – Financial Overview

    Metric

    Value

    Market Capitalisation (₹ Cr)

    8,023.19

    Last Price (₹)

    1,564.55

    52-Week High (₹)

    2,318.30

    52-Week Low (₹)

    1,527.60

    TTM PE Ratio

    52.70

    TTM EPS (₹)

    29.69 (+19.00% YoY)

    P/B Ratio

    6.78

    Book Value Per Share (₹)

    230.87

    Dividend Yield (%)

    0.26

    Return on Equity (%)

    11.66

    Debt to Equity Ratio

    0.00

    Latest Quarterly Revenue

    ₹296.88 Cr (Q3 FY25)

    Source: MoneyControl

    Highlights

    ● Debt-free business with expansion via M&A (e.g., Scientific Pathology, Core Diagnostics).

    ● Q3 revenue rose over 10% YoY.

    ● 1-year price return at -9.23% with sharp YTD correction​.

    Vijaya Diagnostic Centre

    Vijaya Diagnostic Centre Ltd. operates the biggest diagnostic network throughout South India by providing pathology and radiology services. The company operates debt-free while expanding its operations through its strong presence in both Tier I and II cities.

    Vijaya Diagnostic – Financial Overview

    Metric

    Value

    Market Capitalisation (₹ Cr)

    10,337.53

    Last Price (₹)

    1,007.20

    52-Week High (₹)

    1,275.00

    52-Week Low (₹)

    636.60

    TTM PE Ratio

    78.08

    TTM EPS (₹)

    12.90 (+15.49% YoY)

    P/B Ratio

    14.44

    Book Value Per Share (₹)

    69.77

    Dividend Yield (%)

    0.10

    Return on Equity (%)

    17.54

    Debt to Equity Ratio

    0.00

    Latest Quarterly Revenue

    ₹168.98 Cr (Q3 FY25)

    Source: MoneyControl

    Highlights

    ● Net sales up 27.35% YoY in Q3 FY25.

    ● Trades at high P/E and P/B multiples.

    ● Promoter holding steady at 53.91% as of Dec 2024​.

    Thyrocare Technologies

    The diagnostic chain Thyrocare Technologies Ltd. provides automated processing services and focuses on preventive care testing for wellness purposes as it operates internationally. The company expanded its operations through new East African ventures in recent times.

    Thyrocare Technologies – Financial Overview

    Metric

    Value

    Market Capitalisation (₹ Cr)

    3,601.70

    Last Price (₹)

    679.65

    52-Week High (₹)

    1,055.00

    52-Week Low (₹)

    571.40

    TTM PE Ratio

    41.07

    TTM EPS (₹)

    16.55 (+23.84% YoY)

    P/B Ratio

    7.38

    Book Value Per Share (₹)

    92.12

    Dividend Yield (%)

    2.65

    Return on Equity (%)

    13.43

    Debt to Equity Ratio

    0.04

    Latest Quarterly Revenue

    ₹165.92 Cr (Q3 FY25)

    Source: MoneyControl

    Highlights

    ● Consolidated Q3 revenue up 23.14% YoY.

    ● Dividend yield of 2.65% among the highest in the peer group.

    ● Promoter holding slightly reduced to 71.06% in Dec 2024​.

    Suraksha Diagnostic

    Suraksha Diagnostic Ltd. is a relatively new listed player in diagnostics, with a base in Eastern India. It focuses on both pathology and imaging services. While it maintains moderate valuations, it has shown strong top-line growth.

    Suraksha Diagnostic – Financial Overview

    Metric

    Value

    Market Capitalisation (₹ Cr)

    1,349.93

    Last Price (₹)

    259.20

    52-Week High (₹)

    449.00

    52-Week Low (₹)

    231.00

    TTM PE Ratio

    43.34

    TTM EPS (₹)

    5.98 (-98.22% YoY)

    P/B Ratio

    6.78

    Book Value Per Share (₹)

    38.25

    Return on Equity (%)

    13.28

    Debt to Equity Ratio

    0.05

    Latest Quarterly Revenue

    ₹59.51 Cr (Q3 FY25)

    Source: MoneyControl

    Highlights

    ● Q3 net sales up 14.84% YoY.

    ● Publicly listed recently with growing institutional visibility.

    ● Promoter holding stable at 48.78% in Dec 2024​.

    How To Invest In Diagnostics Stocks?


    Investing in diagnostics stocks involves several steps:

    1. Open a Demat Account: To hold shares electronically, you need a demat account.

    2. Set Up a Trading Account: This account allows you to buy and sell stocks on exchanges.

    3. Research Stocks: Analyze various diagnostics companies based on financial performance, market position, and growth potential.

    4. Use a Brokerage Calculator: This tool helps estimate transaction costs associated with buying or selling stocks.

    5. Consider MTF (Margin Trading Facility): For those looking to leverage their investments, MTF can provide additional capital for purchasing stocks.

    6. Monitor Market Trends: Stay informed about industry developments and adjust your investment strategy accordingly.

    By following these steps, investors can effectively navigate the diagnostics stock market and make informed decisions.

    Additional Read: How to Invest in Stocks

    Conclusion

    The Indian diagnostics industry continues to expand rapidly because of growing healthcare service requirements and government backing. The current market growth makes diagnostics stocks an appealing investment opportunity for investors who want to capitalise on this trend. The market sector functions as a tempting investment choice because it benefits from technological advances combined with increasing health-related knowledge and stable market dynamics.

    Before investing it is crucial to use a brokerage calculator for cost estimation and to create trading and demat accounts for smooth transactions. To boost their investment potential investors also need to stay updated on market trends. It helps to develop strategies such as MTF (Margin Trading Facility) and intraday trading.

    Other Popular Stocks in India

    Here are some additional listed diagnostics-related companies in India:

    Krsnaa Diagnostics 
    Operates an extensive network focused on radiology and pathology services across public-private partnerships.

    Vimta Labs 
    Offers specialised services in clinical research and contract laboratory testing, serving both domestic and global clients.

    Medinova Diagnostic Services 
    One of the earlier players in the Indian diagnostics sector, with operations in select regions.

    Narayana Hrudayalaya (diagnostics revenue segment) 
    While primarily a hospital chain, it operates in-house diagnostic labs contributing to overall healthcare services.

     

     

     

    Share this article: 

    Frequently Asked Questions

    Published Date : 20 May 2025

    Disclaimer :

    Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Our Secure Trading Platforms

    Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    9 lakh+ Users

    icon-with-text

    4.9 App Rating

    icon-with-text

    4 Languages

    icon-with-text

    ₹7,300 Cr+ MTF Book

    icon-with-text
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |